B Cell Bosses

Gut bacteria in mice spur regulatory B cells to differentiate and release an anti-inflammatory cytokine.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

MICROBIAL INSTIGATORS: Conventionally housed mice are exposed to ample amounts of bacteria, which colonize their guts. When researchers induce arthritis in the mice by injecting them with foreign antigens, the animals’ macrophages and dendritic cells go into overdrive, producing the cytokines IL-1β and IL-6 (1). These cytokines lead to acute arthritis (2). But they also drive the development of Bregs, which produce the anti-inflammatory cytokine IL-10 that subsequently quells arthritic symptoms (3). Meanwhile, mice raised in a sterile environment or given antibiotics to knock down their gut microbiota (4) suffer less acute arthritis, due to a relative lack of IL-1β, IL-6, and other pro-inflammatory cytokines. They also produce fewer Bregs (5). © KIMBERLY BATTISTA

The paper
E.C. Rosser et al., “Regulatory B cells are induced by gut microbiota–driven interleukin-1β and interleukin-6 production,” Nat Med, 20:1334-39, 2014.

Elizabeth Rosser was partway through her PhD at University College London when her experiments stopped working. Using a mouse model of arthritis, she was trying to understand how invariant natural killer T cells—white blood cells that help guide the body’s response to inflammation—interact with regulatory B cells (Bregs), which put a damper on inflammatory responses. But when the university’s Centre for Rheumatology moved to a new building, experimental mice didn’t get arthritis—and also didn’t develop Bregs.

It is well-known that animals’ immune systems do not always behave the same way in new, very clean housing facilities as in older ones. The literature shows ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Kate Yandell

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours